In the second wave of the deadly coronavirus, the deluge of infections has led to severe health crisis hitting us like a storm. Covid has infected over 3.86 lakh more people in India in yet another worrying daily high and killed 3,498 in the last 24 hours. With a total number of 18.4 million total confirmed cases as on April 30th, 2021 and a total of 2.05 lakh deaths India is sailing through real tough times.
In a large study, severe illness was seen in 15.7% of COVID-19 patients following hospitalization. ARDS leading to respiratory failure is the major cause of death in 70% of fatal COVID-19 cases.
Cytokine storm and symptoms of sepsis are the cause of death in 28% of fatal COVID-19 cases. Critically ill patients mostly go through a sepsis-like condition, cytokine release syndrome and multiple organ failure. Along with the pharmacological approaches, new extracorporeal organ support therapies including hemadsorption and hemoperfusion may be a promising and important therapeutic option to help manage the serious complications in critically-ill COVID-19 infected patients and may aid in rescuing critically ill patients from a deleterious cytokine storm.
There are devices which are indicated in hypercytokinemia and used as adjunct therapies. One such hemadsorption device has received approval for patients 18 years of age or older with confirmed COVID-19 admitted to the ICU is CytoSorb.
We at THE WEEK with support from Biocon Biologics, India’s largest biopharmaceutical company and Indian Medical Association (IMA), the national voluntary organization of doctors of Modern Scientific System of medicine stand with you all in this fight against COVID-19. Our recent endeavour to create awareness about possible healthcare solutions to COVID-19 patients that could bring hope to those in despair was in the form of a conference with India’s top medical minds, policymakers and scientists. The title of the conference was: INDIA FIGHTS FOR A BETTER TOMORROW. The conference facilitated the doctors and intensivists to discuss and share their individual experiences in the Management of Critically- ill COVID Patients and expanding the treatment landscape.
The virtual conference was presided over by Dr.Yatin Mehta, Chairman, Institute of Critical Care & Anaesthesiology, Medanta The Medicity, Gurgaon, Dr.Prachee Sathe, Director, ICU Ruby Hall Clinic, Grant Medical Foundation, Pune, Dr.Aparna Mukherjee, Scientist E, Clinical Trial & Health Research Systems Unit, Epidemiology and Communicable diseases, Indian Council of Medical Research (ICMR), New Delhi, Dr. J.A. Jayalal National President, IMA, Prof. Dr. Zsolt Molnar, Centre of Translational Medicine, Medical School, University of Pecs. Pecs. Hungary and country’s best intensivists nephrologists like, Dr. Abdul Samad Ansari, Director, Critical Care Services, Nanavati Super Speciality Hospital, Mumbai, Dr. Purvesh Umraniya, Consultant Intensivist, Bhailal Amin General Hospital, Baroda, Dr. Niranjan Panigrahi, Consultant, Critical Care Medicine, Apollo Health City, Hyderabad, Dr. Rajib Paul, Sr. Consultant Physician & Intensivist, Apollo Hospital, Hyderabad, Dr. Krishna Patil, Consultant Nephrologist and, Transplant Physician, The Sunshine Hospital, Hyderabad,Dr. Dipanjan Chatterjee Sr. Consultant - Cardiac Anaesthesiology, Critical Care and ECMO Services, Medica Super Specialty Hospital, Kolkata and Dr.S.Rajesh, Director, COVID-19 Management Core Team, Dept. of Health & Research, Ministry of Health & Family Welfare, Govt. of India.
FULL VIDEO OF THE CONFERENCE:
